CYSTITIS HAEMORRHAGIC side effect
What is CYSTITIS HAEMORRHAGIC ?Drugs associated with CYSTITIS HAEMORRHAGIC
ALKERAN AZATHIOPRINE BUSULFAN CEFACLOR CELLCEPT CLAVENTIN CYCLOPHOSPHAMIDE CYMBALTA DACARBAZINE ENALAPRIL ENDOXAN ETOPOSIDE FLUDARABINE FLUOROURACIL GLEEVEC HOLOXAN IMMUCYST IRESSA MELPHALAN METHYLPREDNISOLO MYCOPHENOLATE MYLOTARG PREDNISOLONE PROGRAF PURGED REYATAZ TELZIR TEMODAR THALOMID VIDAZA ZADITENCYSTITIS HAEMORRHAGIC : Melphalan Side Effects Report #5661266-3
Consumer or non-health professional from JAPAN reported MELPHALAN problem on Feb 28, 2008. Female patient, child 11 years of age, was diagnosed with prophylaxis against graft versus host disease and was treated with MELPHALAN. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, . MELPHALAN dosage: 70MGM2 PER DAY. During the same period patient was treated with CYTARABINE, THIOTEPA, CYCLOPHOSPHAMIDE, ETOPOSIDE, STEM CELL TRANSPLANT, TACROLIMUS, METHOTREXATE, METHYLPREDNISOLONE. Patient recovered.
CYSTITIS HAEMORRHAGIC : Melphalan Side Effects Report #5677167-0
MELPHALAN problem was reported by a Physician from JAPAN on Mar 17, 2008. Female patient, child 11 years of age, was diagnosed with acute lymphocytic leukaemia, prophylaxis against graft versus host disease and was treated with MELPHALAN. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, . MELPHALAN dosage: 70MGM2 PER DAY. During the same period patient was treated with CYTARABINE, THIOTEPA, CYCLOPHOSPHAMIDE, ETOPOSIDE, STEM CELL TRANSPLANT, TACROLIMUS, METHOTREXATE, METHYLPREDNISOLONE. Patient recovered.
CYSTITIS HAEMORRHAGIC : Gleevec Side Effects Report #5626001-3
Consumer or non-health professional from JAPAN reported GLEEVEC problem on Feb 07, 2008. Male patient, 19 years of age, weighting 125.7 lb, was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, hypoglycaemia, malignant neoplasm progression, . GLEEVEC dosage: unknown. During the same period patient was treated with GEFITINIB. Patient died on 09/01/2006.
CYSTITIS HAEMORRHAGIC : Fludarabine Side Effects Report #5635614-4
FLUDARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 07, 2008. Male patient, child 8 years of age, was diagnosed with immunosuppression, prophylaxis against graft versus host disease and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, pneumonia, reversible posterior leukoencephalopathy syndrome, . FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, METHYLPREDNISOLONE. Patient recovered.
CYSTITIS HAEMORRHAGIC : Enalapril Side Effects Report #5584649-9
Pharmacist from JAPAN reported ENALAPRIL MALEATE problem on Dec 18, 2007. Female patient was treated with ENALAPRIL MALEATE. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, . ENALAPRIL MALEATE dosage: unknown. Patient was hospitalized. Patient recovered.
CYSTITIS HAEMORRHAGIC : Prograf Side Effects Report #5535118-3
PROGRAF problem was reported by a Physician from JAPAN on Nov 15, 2007. Male patient, child 4 years of age, was diagnosed with bone marrow transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, pseudomembranous colitis, thrombotic microangiopathy, . PROGRAF dosage: unknown. Patient recovered.
CYSTITIS HAEMORRHAGIC : Mylotarg Side Effects Report #5535978-6
Physician from JAPAN reported MYLOTARG problem on Nov 30, 2007. Male patient, 52 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, . MYLOTARG dosage: unknown. During the same period patient was treated with ZOVIRAX. Patient was hospitalized. Patient recovered.
CYSTITIS HAEMORRHAGIC : Vidaza Side Effects Report #5563347-1
VIDAZA problem was reported by a Physician from UNITED STATES on Oct 23, 2007. Female patient, 78 years of age, weighting 141.1 lb, was diagnosed with acute myeloid leukaemia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, platelet count decreased, urinary tract infection, . VIDAZA dosage: 75 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with MGCD. Patient was hospitalized. Patient recovered.
CYSTITIS HAEMORRHAGIC : Cellcept Side Effects Report #5565556-4
Physician from JAPAN reported CELLCEPT problem on Sept 28, 2005. Male patient, 61 years of age, was diagnosed with prophylaxis against graft versus host disease and was treated with CELLCEPT. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, cytomegalovirus infection, thrombotic microangiopathy, . CELLCEPT dosage: unknown. During the same period patient was treated with CYCLOSPORINE, METHOTREXATE, PREDNISOLONE, FLUDARA, BUSULPHAN, ANTITHYMOCYTE GLOBULIN. Patient died.
CYSTITIS HAEMORRHAGIC : Iressa Side Effects Report #5571074-X
IRESSA problem was reported by a Physician from CHINA on Dec 14, 2007. Male patient, 45 years of age, was diagnosed with bronchioloalveolar carcinoma and was treated with IRESSA. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, dry skin, pruritus, rash papular, . IRESSA dosage: unknown. Patient recovered.
CYSTITIS HAEMORRHAGIC : Cyclophosphamide Side Effects Report #5523491-1
Health Professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Nov 19, 2007. Male patient, 14 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, . CYCLOPHOSPHAMIDE dosage: 3 DAILY DOSES WITH 50MG/KG/DOSE. During the same period patient was treated with ETOPOSIDE, MESNA. Patient recovered.
CYSTITIS HAEMORRHAGIC : Zaditen Side Effects Report #5474026-3
ZADITEN problem was reported by a Pharmacist from JAPAN on Sept 21, 2007. Female patient was diagnosed with asthma and was treated with ZADITEN. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, . ZADITEN dosage: 2 MG/DAY. Patient was hospitalized. Patient recovered.
CYSTITIS HAEMORRHAGIC : Claventin Side Effects Report #5482425-9
Health Professional from FRANCE reported CLAVENTIN problem on Oct 08, 2007. Female patient was diagnosed with infection, cystic fibrosis and was treated with CLAVENTIN. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, . CLAVENTIN dosage: unknown. Patient recovered.
CYSTITIS HAEMORRHAGIC : Prograf Side Effects Report #5504682-2
PROGRAF problem was reported by a Physician from JAPAN on Oct 17, 2007. Male patient was diagnosed with bone marrow transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, pseudomembranous colitis, thrombotic microangiopathy, . PROGRAF dosage: unknown. Patient recovered.
CYSTITIS HAEMORRHAGIC : Busulfan Side Effects Report #5447579-9
Health Professional from JAPAN reported BUSULFAN problem on Aug 22, 2007. Female patient, 21 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, diarrhoea, disseminated intravascular coagulation, malaise, multi-organ failure, nausea, neutropenia, staphylococcal sepsis, stem cell transplant, . BUSULFAN dosage: 6.2 ML;BID;IV; 6.2 ML;QID;IV; 6.2 ML;X1;IV. During the same period patient was treated with PHENYTOIN, CYCLOPHOSPHAMIDE, METHOTREXATE, CYCLOSPORINE. Patient died on 05/05/2007.
CYSTITIS HAEMORRHAGIC : Zaditen Side Effects Report #5465275-9
ZADITEN problem was reported by a Pharmacist from JAPAN on Sept 14, 2007. Female patient was diagnosed with asthma and was treated with ZADITEN. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, . ZADITEN dosage: 2 MG/DAY. Patient was hospitalized. Patient recovered.
CYSTITIS HAEMORRHAGIC : Vidaza Side Effects Report #5413136-3
Physician from UNITED STATES reported VIDAZA problem on July 26, 2007. Female patient, 78 years of age, weighting 140.2 lb, was diagnosed with acute myeloid leukaemia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, thrombocytopenia, urinary tract infection, . VIDAZA dosage: 75 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with MGCD, ATENOLOL. Patient was hospitalized. Patient recovered.
CYSTITIS HAEMORRHAGIC : Fluorouracil Side Effects Report #5416842-X
FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 15, 2007. Male patient, weighting 183.4 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, dehydration, dysuria, obstructive uropathy, proctalgia, renal failure acute, . FLUOROURACIL dosage: 7120 MG. During the same period patient was treated with MITOMYCIN. Patient was hospitalized. Patient recovered.
CYSTITIS HAEMORRHAGIC : Cyclophosphamide Side Effects Report #5386686-6
Consumer or non-health professional from GERMANY reported CYCLOPHOSPHAMIDE problem on July 04, 2007. Male patient, 52 years of age, was diagnosed with bone marrow conditioning regimen and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, multi-organ failure, urosepsis, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with UROMITEXAN, HYDROCORTISONE, FOSCARNET. Patient died on 01/27/2007.
CYSTITIS HAEMORRHAGIC : Mycophenolate Side Effects Report #5403916-2
MYCOPHENOLATE MOFETIL problem was reported by a Physician from UNITED STATES on Sept 22, 2003. Female patient, 41 years of age, was diagnosed with necrotising scleritis and was treated with MYCOPHENOLATE MOFETIL. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, diarrhoea, hepatic enzyme abnormal, hypertension, paraesthesia, . MYCOPHENOLATE MOFETIL dosage: unknown. During the same period patient was treated with PREDNISONE, CYCLOSPORINE, METHOTREXATE, CYCLOPHOSPHAMIDE. Patient recovered.
CYSTITIS HAEMORRHAGIC : Cyclophosphamide Side Effects Report #5386686-6
Consumer or non-health professional from GERMANY reported CYCLOPHOSPHAMIDE problem on July 04, 2007. Male patient, 52 years of age, was diagnosed with bone marrow conditioning regimen and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, multi-organ failure, urosepsis, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with UROMITEXAN, HYDROCORTISONE, FOSCARNET. Patient died on 01/27/2007.
CYSTITIS HAEMORRHAGIC : Mycophenolate Side Effects Report #5403916-2
MYCOPHENOLATE MOFETIL problem was reported by a Physician from UNITED STATES on Sept 22, 2003. Female patient, 41 years of age, was diagnosed with necrotising scleritis and was treated with MYCOPHENOLATE MOFETIL. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, diarrhoea, hepatic enzyme abnormal, hypertension, paraesthesia, . MYCOPHENOLATE MOFETIL dosage: unknown. During the same period patient was treated with PREDNISONE, CYCLOSPORINE, METHOTREXATE, CYCLOPHOSPHAMIDE. Patient recovered.
CYSTITIS HAEMORRHAGIC : Azathioprine Side Effects Report #5671843-1
Consumer or non-health professional from UNITED KINGDOM reported AZATHIOPRINE problem on Feb 26, 2008. Female patient, 45 years of age, was diagnosed with systemic lupus erythematosus and was treated with AZATHIOPRINE. After drug was administered, patient experienced the following problems/side effects: bone marrow toxicity, cystitis haemorrhagic, jc virus infection, progressive multifocal leukoencephalopathy, respiratory failure, weight decreased, . AZATHIOPRINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXIMAB, PREDNISOLONE. Patient died.
CYSTITIS HAEMORRHAGIC : Prednisolone Side Effects Report #5685309-6
PREDNISOLONE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 20, 2008. Female patient, 45 years of age, was diagnosed with systemic lupus erythematosus and was treated with PREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: bone marrow toxicity, cystitis haemorrhagic, dysphagia, herpes zoster, pneumonia, progressive multifocal leukoencephalopathy, respiratory failure, weight decreased, . PREDNISOLONE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, AZATHIOPRINE, RITUXIMAB, CORTICOSTEROIDS. Patient died.
CYSTITIS HAEMORRHAGIC : Thalomid Side Effects Report #5637800-6
Physician from UNITED STATES reported THALOMID problem on Feb 12, 2008. Female patient was diagnosed with carcinoid tumour of the pancreas, metastatic neoplasm and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: constipation, cystitis haemorrhagic, deep vein thrombosis, dizziness, dry mouth, fatigue, orthostatic hypotension, peripheral sensory neuropathy, somnolence, . THALOMID dosage: 200 MG, DAILY, ORAL; 400 MG, DAILY, ORAL. Patient recovered.
CYSTITIS HAEMORRHAGIC : Busulfan Side Effects Report #5585749-X
BUSULFAN problem was reported by a Consumer or non-health professional from JAPAN on Dec 21, 2007. Male patient, 43 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: brain stem haemorrhage, cystitis haemorrhagic, disseminated intravascular coagulation, gastrointestinal haemorrhage, infection, pulmonary haemorrhage, sepsis, . BUSULFAN dosage: 29.32 ML; QD; IV. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE. Patient died on 12/17/2006.
CYSTITIS HAEMORRHAGIC : Dacarbazine Side Effects Report #5613644-6
Consumer or non-health professional from UNITED STATES reported DACARBAZINE problem on Jan 16, 2008. Male patient, 63 years of age, was diagnosed with metastatic malignant melanoma and was treated with DACARBAZINE. After drug was administered, patient experienced the following problems/side effects: blood calcium decreased, cystitis haemorrhagic, metastases to central nervous system, . DACARBAZINE dosage: 600MG/M2; 700MG/M2; 850 MG/. Patient was hospitalized. Patient died.
CYSTITIS HAEMORRHAGIC : Alkeran Side Effects Report #5505311-4
ALKERAN problem was reported by a Physician from JAPAN on Oct 29, 2007. Male patient, 77 years of age, weighting 94.80 lb, was diagnosed with multiple myeloma, osteoporosis, gastritis, supraventricular tachycardia, angina pectoris, hyperlipidaemia, benign prostatic hyperplasia, lumbar vertebral fracture and was treated with ALKERAN. After drug was administered, patient experienced the following problems/side effects: anaemia, cystitis haemorrhagic, . ALKERAN dosage: 4MG PER DAY. During the same period patient was treated with PREDONINE, PRIMOBOLAN, ZANTAC, DIGOXIN, AMLODIPINE, PRAVASTATIN, HARNAL, MOBIC. Patient was hospitalized. Patient died on 11/09/2006.
CYSTITIS HAEMORRHAGIC : Holoxan Side Effects Report #5489841-X
Consumer or non-health professional from UNITED STATES reported HOLOXAN problem on Oct 09, 2007. Male patient, child 3 years of age, weighting 33.07 lb, was diagnosed with rhabdomyosarcoma and was treated with HOLOXAN. After drug was administered, patient experienced the following problems/side effects: convulsion, cystitis haemorrhagic, encephalopathy, hyperhidrosis, hypotension, hypotonia, malaise, . HOLOXAN dosage: unknown. During the same period patient was treated with ONCOVIN, KETAMINE, UROMITEXAN, ACTINOMYCIN, ZOFRAN, VOGALENE. Patient was hospitalized. Patient recovered.
CYSTITIS HAEMORRHAGIC : Holoxan Side Effects Report #5490537-9
HOLOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 09, 2007. Male patient, child 3 years of age, weighting 33.07 lb, was diagnosed with rhabdomyosarcoma and was treated with HOLOXAN. After drug was administered, patient experienced the following problems/side effects: convulsion, cystitis haemorrhagic, encephalopathy, hyperhidrosis, hypotension, hypotonia, malaise, . HOLOXAN dosage: unknown. During the same period patient was treated with ONCOVIN, KETAMINE, UROMITEXAN, ACTINOMYCIN, ZOFRAN, VOGALENE. Patient was hospitalized. Patient recovered.
CYSTITIS HAEMORRHAGIC : Cymbalta Side Effects Report #5500863-2
Physician from SLOVAKIA (Slovak Republic) reported CYMBALTA problem on Oct 22, 2007. Female patient, 79 years of age, was diagnosed with depression, abnormal behaviour, agitation, cognitive disorder, hypertension, osteoporosis, myocardial ischaemia, arrhythmia and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, cystitis haemorrhagic, hepatic enzyme increased, . CYMBALTA dosage: 60 MG, QOD. During the same period patient was treated with RISPERDAL, PROTHAZIN, PIRABENE, LORISTA, MODURETIC, CALCITONIN, BISOPROLOL FUMARATE, DIGOXIN. Patient was hospitalized. Patient died on 05/17/2007.
CYSTITIS HAEMORRHAGIC : Reyataz Side Effects Report #5412580-8
REYATAZ problem was reported by a Health Professional from FRANCE on Aug 08, 2007. Female patient, 46 years of age, weighting 121.3 lb, was diagnosed with hiv infection and was treated with REYATAZ. After drug was administered, patient experienced the following problems/side effects: calculus urinary, cystitis haemorrhagic, . REYATAZ dosage: unknown. During the same period patient was treated with TELZIR, EFFEXOR, LARGACTIL, NEURONTIN, CLONAZEPAM. Patient was hospitalized. Patient recovered.
CYSTITIS HAEMORRHAGIC : Telzir Side Effects Report #5413712-8
Consumer or non-health professional from FRANCE reported TELZIR problem on Aug 08, 2007. Female patient, 45 years of age, weighting 121.3 lb, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: calculus urinary, cystitis haemorrhagic, . TELZIR dosage: unknown. During the same period patient was treated with REYATAZ, EFFEXOR, LARGACTIL, NEURONTIN, CLONAZEPAM. Patient was hospitalized. Patient recovered.
CYSTITIS HAEMORRHAGIC : Holoxan Side Effects Report #5429570-1
HOLOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 20, 2007. Male patient, child 3 years of age, was diagnosed with rhabdomyosarcoma and was treated with HOLOXAN. After drug was administered, patient experienced the following problems/side effects: convulsion, cystitis haemorrhagic, hyperhidrosis, hypotension, hypotonia, malaise, . HOLOXAN dosage: unknown. During the same period patient was treated with ONCOVIN, UROMITEXAN, ACTINOMYCIN. Patient was hospitalized. Patient recovered.
CYSTITIS HAEMORRHAGIC : Holoxan Side Effects Report #5431629-X
Consumer or non-health professional from UNITED STATES reported HOLOXAN problem on Aug 20, 2007. Male patient, child 3 years of age, was diagnosed with rhabdomyosarcoma and was treated with HOLOXAN. After drug was administered, patient experienced the following problems/side effects: convulsion, cystitis haemorrhagic, hyperhidrosis, hypotension, hypotonia, malaise, . HOLOXAN dosage: unknown. During the same period patient was treated with ONCOVIN, UROMITEXAN, ACTINOMYCIN. Patient was hospitalized. Patient recovered.
CYSTITIS HAEMORRHAGIC : Purged Side Effects Report #5378116-5
PURGED PERIPHERAL STEM CELLS problem was reported by a Physician from UNITED STATES on July 02, 2007. Male patient, weighting 39.24 lb, was treated with PURGED PERIPHERAL STEM CELLS. After drug was administered, patient experienced the following problems/side effects: adenovirus infection, cystitis haemorrhagic, cytomegalovirus test, enteritis, multi-organ failure, pneumonitis, pulmonary haemorrhage, right ventricular failure, . PURGED PERIPHERAL STEM CELLS dosage: unknown. Patient died on 06/25/2007.
CYSTITIS HAEMORRHAGIC : Temodar Side Effects Report #5389273-9
Pharmacist from UNITED STATES reported TEMODAR problem on July 09, 2007. Male patient, 45 years of age, weighting 330.7 lb, was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: cystitis bacterial, cystitis haemorrhagic, . TEMODAR dosage: unknown. Patient recovered.
CYSTITIS HAEMORRHAGIC : Etoposide Side Effects Report #5392130-5
ETOPOSIDE problem was reported by a Physician from UNITED STATES on July 18, 2007. Male patient, weighting 39.68 lb, was diagnosed with neuroblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cardiac failure, cystitis haemorrhagic, enteritis, graft complication, immunosuppression, multi-organ failure, neutrophil count decreased, platelet count decreased, pneumonia adenoviral, . ETOPOSIDE dosage: 140MG. During the same period patient was treated with CISPLATIN, FILGRASTIM, CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, MESNA. Patient died on 06/25/2007.
CYSTITIS HAEMORRHAGIC : Purged Side Effects Report #5378116-5
Physician from UNITED STATES reported PURGED PERIPHERAL STEM CELLS problem on July 02, 2007. Male patient, weighting 39.24 lb, was treated with PURGED PERIPHERAL STEM CELLS. After drug was administered, patient experienced the following problems/side effects: adenovirus infection, cystitis haemorrhagic, cytomegalovirus test, enteritis, multi-organ failure, pneumonitis, pulmonary haemorrhage, right ventricular failure, . PURGED PERIPHERAL STEM CELLS dosage: unknown. Patient died on 06/25/2007.
CYSTITIS HAEMORRHAGIC : Temodar Side Effects Report #5389273-9
TEMODAR problem was reported by a Pharmacist from UNITED STATES on July 09, 2007. Male patient, 45 years of age, weighting 330.7 lb, was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: cystitis bacterial, cystitis haemorrhagic, . TEMODAR dosage: unknown. Patient recovered.
CYSTITIS HAEMORRHAGIC : Etoposide Side Effects Report #5392130-5
Physician from UNITED STATES reported ETOPOSIDE problem on July 18, 2007. Male patient, weighting 39.68 lb, was diagnosed with neuroblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cardiac failure, cystitis haemorrhagic, enteritis, graft complication, immunosuppression, multi-organ failure, neutrophil count decreased, platelet count decreased, pneumonia adenoviral, . ETOPOSIDE dosage: 140MG. During the same period patient was treated with CISPLATIN, FILGRASTIM, CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, MESNA. Patient died on 06/25/2007.
CYSTITIS HAEMORRHAGIC : Azathioprine Side Effects Report #5663673-1
AZATHIOPRINE problem was reported by a Physician from UNITED KINGDOM on Feb 25, 2008. Female patient, 45 years of age, was diagnosed with systemic lupus erythematosus and was treated with AZATHIOPRINE. After drug was administered, patient experienced the following problems/side effects: bone marrow toxicity, cerebellar syndrome, cystitis haemorrhagic, disease recurrence, dysphagia, herpes zoster, jc virus infection, neutrophil count decreased, no therapeutic response, . AZATHIOPRINE dosage: unknown. During the same period patient was treated with PREDNISOLONE, RITUXIMAB, CYCLOPHOSPHAMIDE. Patient died.
CYSTITIS HAEMORRHAGIC : Busulfan Side Effects Report #5663692-5
Consumer or non-health professional from JAPAN reported BUSULFAN problem on Feb 22, 2008. Male patient, 15 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, anorexia, cystitis haemorrhagic, diarrhoea, hepatitis b, hepatitis post transfusion, nausea, pneumonia, sepsis, . BUSULFAN dosage: 27.48 MGL;QD;IV. During the same period patient was treated with FLUDARABINE, PHENYTOIN, FILGASTRIM, TRACROLIMUS. Patient was hospitalized. Patient recovered.
CYSTITIS HAEMORRHAGIC : Melphalan Side Effects Report #5677164-5
MELPHALAN problem was reported by a Physician from JAPAN on Mar 17, 2008. Female patient, 15 years of age, was diagnosed with acute myeloid leukaemia, prophylaxis against graft versus host disease and was treated with MELPHALAN. After drug was administered, patient experienced the following problems/side effects: adenovirus infection, anaemia, cystitis haemorrhagic, . MELPHALAN dosage: 70MGM2 PER DAY. During the same period patient was treated with STEM CELL TRANSPLANT, ETOPOSIDE, CYTARABINE, TOTAL BODY IRRADIATION, THIOTEPA, CYCLOPHOSPHAMIDE, TACROLIMUS. Patient recovered.
CYSTITIS HAEMORRHAGIC : Endoxan Side Effects Report #5582698-8
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on Dec 27, 2007. Male patient, 28 years of age, was diagnosed with lymphoma, nausea and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, anaemia, cystitis haemorrhagic, diarrhoea, fall, haematuria, infection, septic shock, syncope, . ENDOXAN dosage: unknown. During the same period patient was treated with ETOPOPHOS PRESERVATIVE FREE, EMEND. Patient was hospitalized. Patient recovered.
CYSTITIS HAEMORRHAGIC : Busulfan Side Effects Report #5503593-6
BUSULFAN problem was reported by a Consumer or non-health professional from JAPAN on Oct 15, 2007. Male patient, 15 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: anorexia, cystitis, cystitis haemorrhagic, diarrhoea, graft versus host disease, nausea, pneumonia, sepsis, stomatitis haemorrhagic, . BUSULFAN dosage: 27.48 ML;QD;IV. During the same period patient was treated with FLUDARABINE PHOSPHATE, PHENYTOIN, NEUPOGEN, TACROLIMUS. Patient recovered.
CYSTITIS HAEMORRHAGIC : Methylprednisolo Side Effects Report #5463815-7
Health Professional from UNITED STATES reported METHYLPREDNISOLONE problem on Sept 04, 2007. Male patient, child 5 years of age, weighting 39.46 lb, was diagnosed with immunosuppression and was treated with METHYLPREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: abdominal tenderness, adenovirus infection, cystitis haemorrhagic, diarrhoea, escherichia infection, pyrexia, tachycardia, tachypnoea, . METHYLPREDNISOLONE dosage: unknown. During the same period patient was treated with DACLIZUMAB, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, CEPHALEXIN, CIPROFLOXACIN. Patient was hospitalized. Patient recovered.
CYSTITIS HAEMORRHAGIC : Cefaclor Side Effects Report #5468098-X
CEFACLOR problem was reported by a Health Professional from SINGAPORE on Sept 05, 2007. Female patient, 72 years of age, was diagnosed with skin ulcer and was treated with CEFACLOR. After drug was administered, patient experienced the following problems/side effects: culture urine positive, cystitis haemorrhagic, enterobacter infection, escherichia infection, pathogen resistance, type iv hypersensitivity reaction, . CEFACLOR dosage: unknown. During the same period patient was treated with ERYTHROMYCIN ETHYLSUCCINATE, ERYTHROMYCIN ETHYLSUCCINATE, BACTRIM, MEROPENEM. Patient was hospitalized. Patient recovered.
CYSTITIS HAEMORRHAGIC : Immucyst Side Effects Report #5409769-0
Physician from FRANCE reported IMMUCYST problem on Aug 06, 2007. Male patient, 72 years of age, weighting 167.6 lb, was diagnosed with bladder cancer, atrial fibrillation and was treated with IMMUCYST. After drug was administered, patient experienced the following problems/side effects: bovine tuberculosis, chills, cystitis haemorrhagic, hyperhidrosis, lip oedema, oral herpes, pyrexia, urticaria, . IMMUCYST dosage: unknown. During the same period patient was treated with PLAVIX, FLECAINE LP. Patient was hospitalized. Patient recovered.
CYSTITIS HAEMORRHAGIC : Busulfan Side Effects Report #5422196-5
BUSULFAN problem was reported by a Consumer or non-health professional from JAPAN on Aug 03, 2007. Female patient, child 7 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant rejection, bronchopulmonary aspergillosis, cystitis haemorrhagic, erythema, flushing, pigmentation disorder, staphylococcal sepsis, swelling, venoocclusive liver disease, . BUSULFAN dosage: 20 MG/KG; QD; IV. During the same period patient was treated with CYCLOPHOSPHAMIDE, ETOPOSIDE, VALPROATE, METHOTREXATE, TACROLIMUS. Patient recovered.